Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
- 2024
September 2024 - 57 products
IP
CI
Fesoterodin Spirig HC
retard 4 mg
14
9.02
26.25
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Fesoterodin Spirig HC
retard 4 mg
84
52.66
73.70
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Fesoterodin Spirig HC
retard 8 mg
14
9.45
26.70
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Fesoterodin Spirig HC
retard 8 mg
84
55.38
76.65
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Ferrum-Mepha Inject 100 mg / 2 ml
5 x 2 ml
31.95
51.15
10 %
Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml
Mepha Pharma AG
B / SL / SG
FB
G
IP
Ferrum-Mepha Inject 500 mg / 10 ml
10 ml
31.95
51.15
10 %
Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml
Mepha Pharma AG
B / SL / SG
FB
G
IP
Ferrum-Mepha Inject 1000 ml / 20 ml
20 ml
63.90
85.90
10 %
Dispersion zur Injektion/Infusion: Ferrum 1000mg / 20ml
Mepha Pharma AG
B / SL / SG
FB
G
IP
Ferrum-Mepha Inject 500 mg / 10 ml
5 x 10 ml
159.74
190.15
10 %
Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
XGEVA 120 mg/1 ml
379.81
429.50
10 %
Injection solution in prefilled syringe: Denosumabum 120 mg
Amgen Switzerland AG
A / SL
FB
G
L
IP
Altuvoct 250 I.E.
327.81
377.35
10 %
Lyophilisate and solvent: Efanesoctocogum Alfa 250 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
Altuvoct 500 I.E.
655.61
713.70
10 %
Lyophilisate and solvent: Efanesoctocogum Alfa 500 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
Altuvoct 1000 I.E.
1311.22
1386.35
10 %
Lyophilisate and solvent: Efanesoctocogum Alfa 1000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
Altuvoct 2000 I.E.
2622.44
2731.65
10 %
Lyophilisate and solvent: Efanesoctocogum Alfa 2000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
Altuvoct 3000 I.E.
3933.66
4077.00
10 %
Lyophilisate and solvent: Efanesoctocogum Alfa 3000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
Altuvoct 4000 I.E.
5244.88
5422.30
10 %
Lyophilisate and solvent: Efanesoctocogum Alfa 4000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
CI
Velsipity 2 mg
28
806.18
893.20
10 %
Coated tablets: Etrasimodum 2 mg
Pfizer AG
B / SL
FB
G
L
IP
V/S
Spikevax JN.1 (mRNA-
1273.167), 0.10mg/ml
75.83
97.60
10 %
Moderna Switzerland
GmbH
B / SL
FB
G
L
IP
V/S
Spikevax JN.1 (mRNA-
1273.167), 0.10mg/ml
10
758.30
828.30
10 %
Moderna Switzerland
GmbH
B / SL
FB
G
IP
CI
Casgevy 4-13 x 10e6
cells/ml
PR
PR
k.A.
Vertex
Pharmaceuticals (CH)
GmbH
A
FB
G
IP
Rativor 4 mg/ml
5 x 1 ml
PR
PR
k.A.
Injection solution: Lorazepamum 4 mg/ml
Leman SKL SA
B
FB
G
IP
Rativor 4 mg/ml
10 x 1 ml
PR
PR
k.A.
Injection solution: Lorazepamum 4 mg/ml
Leman SKL SA
B
FB
G
IP
Altuvoct 750 I.E.
PR
PR
k.A.
Lyophilisate and solvent: Efanesoctocogum Alfa 750 UI
Swedish Orphan
Biovitrum AG
B
FB
G
Docetaxel Zentiva 20 mg/1 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 20 mg/ml
Helvepharm AG
A
FB
G
Docetaxel Zentiva 80 mg/4 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 80mg / 4ml
Helvepharm AG
A
FB
G
Docetaxel Zentiva 160
mg/8 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 160mg / 8ml
Helvepharm AG
A
FB
G
IP
Winrevair 45 mg
PR
PR
k.A.
Dry substance: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Winrevair 45 mg
2
PR
PR
k.A.
Dry substance: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Winrevair 60 mg
PR
PR
k.A.
Dry substance: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Winrevair 60 mg
2
PR
PR
k.A.
Dry substance: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
Bupropion Accord XR 150 mg
10
PR
PR
k.A.
Delayed release tablets: Bupropioni Hydrochloridum 150 mg
Accord Healthcare AG
B
FB
G
Bupropion Accord XR 150 mg
30
PR
PR
k.A.
Delayed release tablets: Bupropioni Hydrochloridum 150 mg
Accord Healthcare AG
B
FB
G
Bupropion Accord XR 150 mg
90
PR
PR
k.A.
Delayed release tablets: Bupropioni Hydrochloridum 150 mg
Accord Healthcare AG
B
FB
G
Bupropion Accord XR 300 mg
10
PR
PR
k.A.
Delayed release tablets: Bupropioni Hydrochloridum 300 mg
Accord Healthcare AG
B
FB
G
Bupropion Accord XR 300 mg
30
PR
PR
k.A.
Delayed release tablets: Bupropioni Hydrochloridum 300 mg
Accord Healthcare AG
B
FB
G
Bupropion Accord XR 300 mg
90
PR
PR
k.A.
Delayed release tablets: Bupropioni Hydrochloridum 300 mg
Accord Healthcare AG
B
FB
G
IP
CI
Afenadin 120
10
PR
PR
k.A.
Coated tablets: Fexofenadini Hydrochloridum 120 mg
NOBEL Pharma Schweiz AG
D
FB
G
IP
CI
Afenadin 120
30
PR
PR
k.A.
Coated tablets: Fexofenadini Hydrochloridum 120 mg
NOBEL Pharma Schweiz AG
D
FB
G
IP
Afenadin 180
10
PR
PR
k.A.
Coated tablets: Fexofenadini Hydrochloridum 180 mg
NOBEL Pharma Schweiz AG
D
FB
G
IP
Afenadin 180
30
PR
PR
k.A.
Coated tablets: Fexofenadini Hydrochloridum 180 mg
NOBEL Pharma Schweiz AG
D
FB
G
Omjjara 100 mg
30
PR
PR
k.A.
Coated tablets: Momelotinibum 100 mg
GlaxoSmithKline AG
A
FB
G
Omjjara 150 mg
30
PR
PR
k.A.
Coated tablets: Momelotinibum 150 mg
GlaxoSmithKline AG
A
FB
G
Omjjara 200 mg
30
PR
PR
k.A.
Coated tablets: Momelotinibum 200 mg
GlaxoSmithKline AG
A
FB
G
IP
CI
Pomalidomid Viatris 1mg
14
PR
PR
k.A.
Capsules: Pomalidomidum 1 mg
Viatris Pharma GmbH
A
FB
G
IP
CI
Pomalidomid Viatris 1mg
21
PR
PR
k.A.
Capsules: Pomalidomidum 1 mg
Viatris Pharma GmbH
A
FB
G
IP
Pomalidomid Viatris 2mg
14
PR
PR
k.A.
Capsules: Pomalidomidum 2 mg
Viatris Pharma GmbH
A
FB
G
IP
Pomalidomid Viatris 2mg
21
PR
PR
k.A.
Capsules: Pomalidomidum 2 mg
Viatris Pharma GmbH
A
FB
G
IP
Pomalidomid Viatris 3mg
14
PR
PR
k.A.
Capsules: Pomalidomidum 3 mg
Viatris Pharma GmbH
A
FB
G
IP
Pomalidomid Viatris 3mg
21
PR
PR
k.A.
Capsules: Pomalidomidum 3 mg
Viatris Pharma GmbH
A
FB
G
IP
Pomalidomid Viatris 4mg
14
PR
PR
k.A.
Capsules: Pomalidomidum 4 mg
Viatris Pharma GmbH
A
FB
G
IP
Pomalidomid Viatris 4mg
21
PR
PR
k.A.
Capsules: Pomalidomidum 4 mg
Viatris Pharma GmbH
A
FB
G
IP
CI
Skyclarys 50 mg
90
PR
PR
k.A.
Capsules: Omaveloxolonum 50 mg
Biogen Switzerland AG
B
FB
G
IP
CI
Skyclarys 50 mg
270
PR
PR
k.A.
Capsules: Omaveloxolonum 50 mg
Biogen Switzerland AG
B
FB
G
IP
Caspofungin Leman 50 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Caspofunginum 50 mg
Leman SKL SA
A
FB
G
IP
Caspofungin Leman 70 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Caspofunginum 70 mg
Leman SKL SA
A
FB
G
IP
Polysium Leman
450 g
PR
PR
k.A.
poudre pour suspension orale et rectale: Natrii Polystyrensulfonas 999.34 mg
Leman SKL SA
B
FB
G
Omlyclo 75 mg/0.5 ml
PR
PR
k.A.
solution injectable en seringue préremplie: Omalizumabum 75mg / 0.5ml
iQone Healthcare
Switzerland SA
B
FB
G
Omlyclo 150 mg/1 ml
PR
PR
k.A.
solution injectable en seringue préremplie: Omalizumabum 150 mg/ml
iQone Healthcare
Switzerland SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
